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VASCULARIZATION IN INTERCONNECTED 3D PRINTED TI-6AL-4V FOAMS
WITH HYDROGEL MATRIX FOR BIOMEDICAL BONE REPLACEMENT
IMPLANTS

Abstract:
Vascularization or angiogenesis on newly implanted metal orthopedic implants has remained a
challenge in the field of tissue engineering. In this research, an interconnected foam structure of
Ti-6Al-4V was micro-fabricated by Electron Beam Melting (EBM) technique. The foam in
question has a density of 1.77g/cm3 with 60% porosity and a tensile strength of 18GPa. An
Extracellular Matrix based hydrogel will be added as an aqueous matrix to the foam in question.
Hypoxia mimetic stress has been closely related to many wound healing biomedical applications
because it increases survival and proliferation molecular signals. To that end, increased
expression of Hypoxia-Inducible Factor-1α (Hif-1α) and Vascular Endothelial Growth Factor
(VEGF) in the aqueous hydrogel matrix was achieved by the addition of a hypoxia mimetic
Deferoxamine Mesylate (DFM). In this study, the formation and characterization of newly
formed vascular structures was performed. Cellular viability, fluorescent microscopy and SEM
imaging analysis demonstrate that cells undergo proliferation and also attach efficiently to the
foam when exposed to DFM. Human Umbilical Vascular Endothelial Cells (HUVECs) were
grown in an Extracellular Matrix-like 3D hydrogel and a hypoxia-like stress was achieved. It has
been also demonstrated that pre-osteoblast cells undergo cell differentiation and increase the
production of hydroxyapatite upon the hypoxia mimetic molecule. This proposed approach
encompasses an ideal prototype for a completely living implanted structure for future orthopedic
implants.
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Chapter 1: Introduction
1.1: Tissue Engineering of Bone
3D printing or Additive Manufacturing (AM) has revolutionized the way materials
scientists and engineers synthesize a broad spectrum of materials. This technology allows
bioengineers to enhance metals, composites, polymer plastics, and, in the context of this
research: biomedical devices. Tissue engineering is an emerging field, in which materials that
display biomimetic properties are employed for medical applications. A “tissue engineering”
query in NCBI PubMed yields 75,700+ publications in this field, most of which have been
published in the past decade (figure 1), with bone/cartilage orthopedic implant engineering being
the most popular research area. Despite the considerable amount of research advances being
made [1-6], the main challenge in tissue engineering is to create a fully functional living system
parting from a non-living scaffold. There exists an ever present need to develop materials that are
not just bio-compatible, but that can more closely mimic a complete biological system. Living
tissue is comprised of complex interactions between different cell types, all of which perform
different tasks, depending on the cell type and the type of tissue they happen to be present in.
Due to the highly regulated cell biology processes, complexity of molecular interactions and
cellular differentiation hierarchy, engineering tissue remains a challenging endeavor. Bone is
composed mainly of mineralized calcium crystals (hydroxyapatite), with a chemical formula of
Ca5(PO4)3(OH), and collagen. The mixture of these structures provides mechanical support and a
degree of elasticity [7]. Despite the success of implanted orthopedics, mainly hip-replacement
implants, there has been piling evidence of infection, aseptic loosening, pain without loosening
or other reasons of failure [8]. When a bone replacement implant is inserted, a surgeon needs to
cut an extensive amount of bone, effectively creating a wound. Cells at the interface between the
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bone and the implant cannot grow into the solid bio-compatible metal alloy. Bone replacement
implants remain as solid structures, providing a physical limitation for cells to grow.

12000

Number of PubMed "Tissue Engineering" related
publication timeline
PubMed Tissue
Engineering
Publication
Timeline

Number of Publications

10000
8000
6000
4000
2000
0
1920

1940

1960

Year

1980

2000

2020

Figure 1: A timeline plot of “tissue engineering” research publications in PubMed.
Circled is the number of publications so far in 2016.
Many strategies have been employed in order to enhance the bio-compatibility of
orthopedic implants [9-14], but a more diverse set of materials needs to be examined in order to
closely mimic a complete living system. To this end, 3D printed Ti-6Al-4V foams are an
effective alternative, given their degree of porosity. Advantages to this approach include varying
pore size gradient, varying porosity, and a high degree of resolution control on the implant
synthesis. An extracellular matrix-like gel in combination with 3D printed Ti-6Al-4V foams was
evaluated for the development of a bone replacement implant. In this research, a Ti-6Al-4V foam
structure was designed to promote cell migration of vascular endothelial cells and differentiation
and proliferation of pre-osteoblast cells. Given that there is a degree of porosity in these foams, a
matrix can be applied to the structure; allowing for microcapillarity formation in a 3D
2

suspension. A representative image of the manufactured implant is shown in figure 2. Since
hydrogels are highly hydrated polymers, certain molecules and growth factors can be mixed into
it, providing cells with the necessary supplements required for proliferation and growth.

Figure 2: A representative image of a 3D printed Ti-6Al-4V foam knee replacement
implant.
Hydrogels have been widely employed in cell culture environments, with varied
applications [14-15]. Many materials have been examined and tested for applications in the
biomedical field, but one of the most promising materials have been gelatin based hydrogels [15,
16-17]. Developing a 3D matrix to grow cells in is advantageous in many ways, given that it has
been previously shown [18] that a 2D environment does not fully mimic physiological conditions
to an extent. This is because the matrix will allow cells to behave as they would in a normal
physiological environment, morphologically and also enhancing cell-cell communication [19].
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This research focuses on determining the ability of the before mentioned materials to
drive vascularization, and enhance bone repair, while maintaining mechanical and structural
similarities with real bone.
1.2: Angiogenesis
The process of the development of new vasculature (angiogenesis) is of extreme
importance in the process of wound healing [20]. Vascular structures serve as transport pathways
for oxygen, nutrients and signaling molecules throughout the organismal systems. Because of the
significance of this process, the capacity of implant to induce vascularization is essential to
develop an ideal substitute of the original biological matter. It has been recently studied that cellcell differentiation in developing organs is key for the development of angiogenesis [21-22].
These interactions are mediated by Endothelial Cells (EC). It is these cells that form the first
liner that becomes the basic template for the formation of veins and arteries. The main role of an
endothelium is to serve as a transport pathway for oxygen. Therefore, ECs are equipped with
oxygen sensor molecules such as Prolyl Hydroxylase Domain Enzymes (PHDs), and Hypoxia
Inducible Factors-1α (Hif-1α). Despite the biological importance of vascular structure formation,
achieving this remains the main challenge in tissue engineering [23].
Angiogenesis can be initiated by certain growth factors, the most widely acknowledged
signaling pathway being triggered by Vascular Endothelial Growth Factor (VEGF). Research has
demonstrated that certain proteins, regulate the levels of VEGF secretion and play key roles in
angiogenesis [24], the most important of these being the Hif-1α. Hif-1α acts as a transcription
factor, translocating to the cell’s nucleus under depravation of oxygen. This transcription factor
increases the number of type H ECs and osteoprogenitors through the process of hypoxia [15].
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Hypoxia is defined as the deficiency of oxygen in tissues. When oxygen is depleted in
tissue, a highly regulated process concerning cell survival becomes activated. Hif-1α is highly
down-regulated by PHD-2 which target Hif-1α for degradation (Figure 4). During hypoxia, there
is lack of oxygen in cells, which inactivates the prolyl hydroxylase domain proteins PHD1–3,
which are oxygen-sensing [25]. When this occurs, Hif-1α and Hif-2α proteins are no longer
targeted for protein degradation and transcriptional responses are then activated to increase
oxygen supply by angiogenesis through upregulation of VEGF [19 26]. In general, Hif-1α
promotes vessel sprouting, whereas Hif-2α mediates vascular maintenance [19 26]. Hif-1α
abrogation by siRNAs in HUVECs disrupts the formation of microcapillarities, but not Hif-2α
[27]. This is because Hif-2α does not stimulate the production of VEGF [27].
ECs migrate to reorganize themselves under hypoxia [28]. The secretion of VEFG
stimulates this reorganization. When VEGF is secreted, ECs also secrete metalloproteinases,
whose role is to rearrange the ECM [29]. After the ECM rearrangement, they begin to express
CD44, allowing for an increased cell adhesion [30] that enables the endothelium to maintain is
microcapillar structure. Despite the high level of cellular organization to form microcapillarities,
microvessel maturity is an issue as well. When microcapillarities form, endothelial cells may
become quiescent (increased cellular half-life). However, the microsvascular structure may not
always be retained, unless the endothelium recruits a pericyte liner. Pericytes are recruited by the
endothelium when endothelial cell quiescence is achieved, which is determined by the secretion
of Angiopoetin 1 & 2 (ANG-1 & ANG-2). The secretion of ANG-1 signals endothelium
quiescence, whereas ANG-2 is secreted by Endothelial Tip Cells (ETCs) [24]. An ETC is a
single endothelial cell randomly selected to commence the progression of a sprouting
microvasculature (figure 3). This process promotes vascular branching.
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Figure 3: The process of formation of new vasculature from an existing vasculature
(angiogenesis) and the role of ETCs in the guidance of said process. From 298, Nature. Vol 473.
19 May 2011.
In a physiological environment, ECs are held together by the Extracellular Matrix
(ECM). This is a matrix represents a physical barrier that the endothelium can manipulate [28],
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Figure 4: The angiogenic signaling pathway: An endothelial cell (above) secreting
signaling growth factors, cytokines and ECM remodeling proteins to pericytes. From Cell
Signaling Technology.
It has been previously reported that hypoxia induced by exposing cells in vitro and in
vivo to CoCl2 causes severe inflammatory response, resulting in the recruiting of macrophages
[31]. This has been observed in failed implanted structures that consist mainly of CobaltMolybdenum-Nickel alloys [8]. In this particular research, particulate debris from the implanted
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alloy was analyzed against macrophages, resulting in hypoxia. The authors analyzed the effects
of Cobalt ions on cells, but did not evaluate hypoxia mimetic cellular response with anything
other than Cobalt based materials. Despite these results, there have been a myriad of results
demonstrating that hypoxic stress does not mediate cell death, instead, it promotes cell survival
[32]. It has been widely studied that Cobalt ions can stimulate the production of Reactive
Oxygen Species (ROS), thus leading to mitochondrial insult, resulting in apoptosis [8, 33]. This
leads to a controversial issue: does necessarily a hypoxia mimetic environment cause an
undesirable response in wound healing?
1.3: Hypoxia in wound healing
Cells have evolved to respond to varied environments. Lack of free oxygen is one of
them. Because oxygen is required for many cellular metabolic processes, such as the production
of Adenosine Triphosphate (ATP), fatty acid synthesis and oxidative phosphorylation, cells are
prepared to activate transcription factors that promote cell survival [34]. Under a hypoxic
response, the Hif-1α intracellular levels increase, as it is no longer targeted for degradation by
PHD enzymes [35]. Hif-1α can then dimerize with Hif-1β in the cell nucleus and initiate the
transcription process that results in the expression of the VEGF gene. VEGF has been reported to
promote an angiogenic response, and increase the activation of the Phosphatidyl Inositol-3Kinase (PI3K)-Akt signaling pathway [36]. It has been broadly researched and acknowledged
that this particular signaling pathway is actively involved in the progression of tumor
invasiveness and metastasis in a variety of cancer models [37]. Hypoxia has been reported to
increase the viability of cells and progression of survival signaling pathways [36, 38]. However,
on a normal cell line, inhibiting the degradation of Hif-1α inhibits apoptosis, does not produce
ROS (as Cobalt does), but results in promoting cellular differentiation and migration. Moreover,
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because the PI3K-Akt pathway becomes activated while a cell is experiencing a hypoxic
response, therefore, diligent care must be taken in order to, not only select an appropriate
hypoxic inducer, but to employ it at the correct concentrations. Despite the molecular signaling
similarities between hypoxia stressed cells and cancer, the metabolic profiles of each are
different [39]. This suggests that, though the PI3K/AKT pathway is expressed, no adverse effects
such as the immortalization of cells should be observed, to the best of the author’s knowledge.
The viability, proliferation, and population doublings of the cells exposed to various hypoxia
inducing molecules must be addressed, and must not be limited to endothelial cells. In this
research, pre-osteoblast viability, differentiation, and ability to mineralize calcium is analyzed in
order to select the proper concentration of a hypoxia inducer.
Deferoxamine Mesylate (DFM) (figure 5), also referred to as Deferoxamine (DFO) is an
iron chelating agent; meaning that it binds to free iron ions in solution. This particular molecule
is employed to regulate iron homeostasis in cells by chelating excess iron in solution [40, 41].
Removal of free iron has also been shown to increase bone density in osteoporosis mouse models
[42]. Despite there being other chemicals that may induce hypoxia in cells, i.e. CoCl2 [43], DFM
has little known adverse effects.

Figure 5: The molecular structure of DFM. Image from Sigma Aldrich.
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Figure 6: Proposed PHD inhibitory pathway. DFM counter-inhibits the biological
degradation of Hif-1α, thus inducing a state of hypoxia and promote angiogenesis.
PHD enzymes require iron co-factors in order to add hydroxyl groups to proline residues.
Because DFM binds to iron co-factors, the catalytic ability of PHD enzymes becomes
hindered, leading to the stabilization of Hif-1α. DFM has been approved by the Food and Drug
Administration (FDA) and is available for clinical use in the US. Currently, it is being used as an
iron chelating agent to treat iron overdose from blood transfusions. As previously mentioned
CoCl2 triggers a hypoxic response and stabilized Hif-1α because it competes with iron for
enzymatic active sites. In the 1950s, CoCl2 was used to treat anemia, but was then removed from
the market due to toxicity issues. Both in vivo and in vitro, CoCl2 decreases cellular viability by
increase of oxidative stress [33, 44].

Figure 7: The crystallized structure of PHD2. A Fe(II) co-factor is required in the
catalytic domain of the enzyme, serving as an oxygen sensor[45].
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A wide number research papers have been published with promising applications for
hypoxia in wound healing [39, 46] in recent years. These approaches include but are not limited
to diabetic wound healing in fibroblasts [47], several mitochondrial related metabolic diseases
such as Leigh Syndrome [48], and more recently to treat brain hemorrhage [49 Leah R. Hanson].
The biomedical applications of hypoxia can be tailored to combat a variety of wound healing
situations. It has also been recently reported that inhibiting PHD2 enzymes and stabilizing Hif1α increases the survival rate of newly implanted cells in bone [39]. In this research paper, the
authors demonstrate that the levels of ROS species in endothelial cells decreases, enabling cells
to undergo redox homeostasis and glycogen storage. This further suggests that a hypoxia
mimetic, but not hypoxia as a lack of oxygen maintains the integrity of cellular metabolism by
stabilizing Glutathione S Transferase (GST). Because of the ever increasing evidence that
hypoxia can support regenerative medicine, in this research, a hypoxia mimetic will be applied to
promote vascularization, pre-osteoblast differentiation and wound healing for newly implanted
bone replacement implants.
1.4: Extracellular matrix-like hydrogels for bone repair
The ingrowth of bone into the implant is essential in order to achieve what is
conceptually a “living implant”. Although the main goal of this research is to stimulate the
formation of vascular structures within the porous metal implant, the nature of wound healing
must also be addressed. This includes, but is not limited to the mineralization of calcium by
osteoblasts, the inhibition of bone resorption by osteoclasts, and avoiding debris release by the
implant itself. Bone has elastic properties, and its elasticity can be attributed to the collagen in
which hydroxyapatite grows. The molecular arrangement of collagen is regulated by fibroblasts
and endothelial cells in tissue [50], and this arrangement directs the synthesis and growth of
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hydroxyapatite. Bone is capable of self-repair, but this natural process is limited to the extents to
which it can generate new tissue. This is the case for the large portion of bone that has been
surgically removed. However, with the assistance of engineered biomaterials, bone tissue repair
can be directed by stimulating the appropriate wound healing response. The microenvironment
of bone has been widely reported to be hypoxic [51]. A hypoxia mimetic environment has been
reported to enhance bone repair, along with restoring endothelium integrity [52]. This was
determined by injecting DFM on mandibular fractures that had been exposed to radiotherapy.
DFM improved healing and augmented vascularity. Iron chelation by DFM administration has
also shown that bone resorption is inhibited by limiting osteoclastic differentiation [53, 54]. It is
to this end that a collagen based hydrogel material is ideal to, not only serve as a mimetic of an
ECM, but to also serve as an aqueous solution in which to deliver hypoxia mimetic inducing
compounds such as DFM.
The implementation of a hydrogel matrix also eliminates the issue of seeding efficiency
of cells into the foam structure. When cells are added to the structure, they will be in a liquid
suspension that will eventually become a solid hydrogel matrix. Because the proposed model
will have a solid matrix, cells will not fall through the porous metal foam at the moment of
seeding. Instead, they will remain suspended in the ECM-like gel.
1.5: The concept of a living implant
The main goal of this research is to design a bone replacement implant capable of
forming vascular structures in a hydrogel matrix, while allowing for osteoblast proliferation and
cell differentiation is presented. Osteoblasts can also successfully synthesize hydroxyapatite and
retain their adhesion to the Ti-6Al-4V foam [55]. The hydrogel matrix should contain all of the
necessary supplements to favor angiogenesis and vascular structure maturation.
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Ultimately, this approach will produce what will become a prototype of a living implant;
an engineered mixture of materials that will work to orchestrate appropriately all of the
biological processes of real bone.
1.6: Specific aims of research
1. To design and create a living bone replacement implant, capable of promoting cell and
molecular processes of real tissue.
2. Achieve vascular structure formation in the proposed mixture of biomaterials.
3. Promote synthesis of hydroxyapatite and drive osteogenesis through a hypoxia mimetic
response.
4. Stimulate cell survival in various cell types found in bone tissue to increase viability in
wound healing through DFM exposure in the mixture of biomaterials.
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Chapter 2: Materials & Methods
2.1: Material fabrication, preparation and characterization
An interconnected foam structure of Ti-6Al-4V was micro-fabricated by Electron Beam
Melting (EBM) techniques. The spherical powder size that was used was in the range of 30µm.
We used an ARCAM-EBM system for the fabrication of foam structures. The density was
determined by using the Archimedes Principle for sintered powder metallurgy products ASTM
B962-13.
The foam structures fabricated via the EBM system were qualitatively characterized by
scanning electron microscopy (SEM) and quantitatively through a densitometry approach. The
pore size was estimated from the SEM micrographs, whereas, porosity and modulus were
calculated from densitometric measurements using the following equations:
% 𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦 = [1 −

𝜌
] 𝑋100
𝜌0

𝐺𝑖𝑏𝑠𝑜𝑛 − 𝐴𝑠ℎ𝑏𝑦 𝑒𝑞𝑢𝑎𝑡𝑖𝑜𝑛
𝐸
𝜌 𝑛
=( )
𝐸0
𝜌0
where E and Eo are the stiffness for an open-cellular structure and solid (fully dense) material
having a density of ρ and ρ0, respectively. For Ti-6Al-4V alloy, Eo =110 GPa, ρ0 =4.43 g/cc, n
varies from ~1.8–2.2, and can be approximated to be 2.
2.2: Implementation of a hydrogel matrix on the Ti6-4Al-V foam
In order to produce a fully functional orthopedic implant, an aqueous matrix needs to be
added to the printed foam structures. Cells may grow freely in this structure so they may behave
as they would in normal tissue. The cell biology of angiogenesis is a tightly regulated and
complex process, orchestrated only when necessary. A myriad of cell types, such as endothelial
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cells, pericytes, osteoblasts, etc. have roles to fulfill in the process off wound healing in bone, all
of which need to interact with each other, differentiate and migrate in 3D tissue for complete
wound healing. The process of wound healing includes the re-establishing of osteoblast mediated
synthesis of calcium oxalate, the ability of endothelial cells to form a microvasculature and
ensuring the maturity and stability of said vasculature.
Given that there is such a high level of cellular organization in the process of forming
new vasculature, the aqueous matrix employed in this research needs to be as similar to an Extra
Cellular Matrix (ECM) as possible. To this end, Corning® Matrigel®Matrix was evaluated as a
potential matrix, given that its main constituents are ECM proteins such as laminin, collagen IV,
heparin sulfate proteoglycans, entactin/nidogen, and a number of growth factors.
2.3: Cell culture
The MC3T3-E1 Subclone 4 (mouse pre-osteoblasts (ATCC® Manassas, VA, USA CRL 2593™)) cell line was used as a pre-osteoblast model for this research. MC3T3-E1 Subclone 4
were grown in α-MEM (Alpha Minimum Essential Medium) (Sigma-Aldrich) cell medium
supplemented with 10% FBS (Fetal Bovine Serum) (ATCC 30-2020).
Human Umbilical Vein Endothelial Cells (HUVECs), (ATCC® Manassas, VA, USA
CRL-1730™) will be grown in 1:1 F-12K/DMEM media supplemented with 10% FBS, 0.1
mg/ml heparin; 0.03-0.05 mg/ml endothelial cell growth supplement (ECGS) (Sigma-Aldrich).
Cells will be incubated in a 5% CO2 environment at 37⁰C.
Cell media is changed every two days and washed with 1X PBS solution with every
media change for the MC3T3-E1 cells. HUVEC cell media is aspirated and centrifuged at
1,500rpm for 5min in order to collect cellular debris that is essential for their proliferation. Cells
are sub-divided by trypsin method. Cells are incubated with 0.25% trypsin/EDTA solution for 5-

15

7 minutes until cells are no longer attached to the bottom of the culture vessel, stained with
Trypan Blue exclusion dye and counted using a hemocytometer.
2.4: Seeding Efficiency
Cellular Ti-6Al-4V alloy foam structures and metallographically polished flat Ti-6Al-4V
alloy samples were seeded with pre-osteoblasts (200,000cells/well in a 12 well cell culture plate)
and incubated for 12h at 37°C in a CO2 incubator to examine cell seeding efficiency. After
incubating for 12h, the specimens were removed from their respective wells with a trypsin
solution and the cells remaining in each well were stained with Trypan Blue and counted using
hemocytometer. The number of live cells estimated from the hemocytometer was subtracted
from the total number of initially seeded cells, to obtain the number of cells that were seeded on
each specimen. The seeding efficiency value was calculated as described in the following
equation:
% 𝑆𝑒𝑒𝑑𝑖𝑛𝑔 𝐸𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦
(𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑠𝑒𝑒𝑑𝑒𝑑) − (𝐶𝑒𝑙𝑙𝑠 𝑎𝑡𝑡𝑎𝑐ℎ𝑒𝑑 𝑡𝑜 𝑡ℎ𝑒 𝑤𝑒𝑙𝑙)
=(
) 𝑋100
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑠𝑒𝑒𝑑𝑒𝑑
2.5: MTS Viability Assay protocol
To study lethal effect that DFM may have on MC3T3-E1 and HUVEC cells, an MTS
viability assay (Promega) was performed. Hypoxia itself has not been reported to be cytotoxic to
cells; however, some compounds may trigger a hypoxic response and produce a cytotoxic
response, such as CoCl2. In this experiment, the viability of both pre-osteoblasts and endothelial
HUVEC cells will be compared with exposures of 1:5 dilutions of DFM and CoCl 2 as a positive
toxic response at various time exposures (24h, 48h, 72h, 5 days & 14 days). In order to
determine which concentrations of DFM are toxic to both MC3T3-E1 cells and HUVECs, an
initial test will be performed. This will consist in seeding 50,000 cells/well in a total volume of
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200μL of media with the 1:5 dilutions ranging from 2mM to 640nM of each compound. The
starting stock solution of both hypoxia inducers was 10mM. Cell media was changed every three
days during the time of the experiment to avoid starvation related issues.
For cells grown in 3D printed foams, pre-osteoblast cells will be seeded as previously
described at a density of 200,000cells/well in 12 well cell culture plates containing the 3D
printed Ti-6Al-4V scaffold disks for the previously specified amount of time and dilutions of
DFM. For this experiment, a negative control consists of cells growing of the tissue culture plate.
After the desired periods of incubation, the scaffold will be removed from the well with the cells
attached to it to a new plate. Trypsinizing cells growing on foam samples has previously proven
to produce inconsistent results and also requires extended trypsin incubation, leading to cellular
detriment that may alter the viability results. It is for this reason that viability will be measured
without having to remove the cells from the foams by using the Vybrant® CFDA SE Cell Tracer
Kit (Invitrogen). Fresh complete α-MEM media is added to the foams with cells. Subsequently
each foam is treated with 1μM of Vybrant® CFDA SE reagent A dissolved in reagent B, as
indicated by the kit’s specifications.

To perform the viability assay, 20µL of the MTS stock solution (2mg/mL) was added to
each well. A negative control of 20µL of the MTS stock solution added to 100µL of medium was
included. The 96 well plate was incubated at 37°C for 4 hours and read absorbance at 490nm. All
experiments were performed in triplicates for statistical significance.

2.6: Combinatorial dose of DFM & D(+) Glucose viability analysis in HUVECs and
MC3T3-E1 cells
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Cells that undergo hypoxia mimetic stress mediated by Hif-1α have been reported to
increase their metabolic demands. To test how metabolic demands change in cells exposed to
DFM, both HUVECs and MC3T3-E1 cells were exposed to 3.2μM DFM, 5mM D(+) glucose
and a combination of 3.2μM DFM + 5mM D(+) glucose for 24 hours. A negative control
consisted to both cell types without treatment. The viability of cells was determined by MTS
viability assay. The purpose of this approach is to determine whether D(+) glucose can be used
as an additive in the hydrogel matrix to improve wound healing and help drive vascularization
and osteogenesis process.

2.7: Cell Proliferation Analysis

Cell proliferation is analyzed by counting cells by the trypan blue exclusion dye test.
MC3T3-E1 cells are seeded at 50,000cells/well and exposed to 1:5 dilutions of DFM and CoCl2
in 200μL total volume for 24h, 48h, 72h, 5 days & 14 days. Cells were then trypsinized, stained
and counted. The population of live cells was determined by cell count. Each exposure was
performed in statistical triplicates.

2.8: Fluorescent Microscopy

Pre-osteoblasts seeded on foam structures were cultured for 7 days to test for similar cell
behavior as reported by Nune et al. Cells were seeded at 200,000cells/well in a 12 well plate,
1mL total media volume and then stained with Hoechst 33342 cell nuclei dye. A second
experiment was performed once the appropriate concentration of DFM was selected. In this
experiment, pre-osteoblasts were seeded at the previously described concentration in the same
conditions but exposed to 3.2μM DFM. Proliferation was observed after 21 days exposure. A
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second stain was performed with Vybrant® CFDA SE Cell Tracer Kit to visually determine the
viability of cells without disturbing the layer of cells grown in the foams.

Because the scaffold is solid metal, light cannot be transmitted through it if fully dense.
However, due to the foam nature of the scaffold, light may be transmitted though the medium
and a visible image can be obtained if the metal section is thin enough. Despite the fact that a
thin section makes fluorescent microscopy feasible, since the scaffold is 3D, focus is lost in the z
axis and there is a lack of clarity for morphological details. Improvements on microscopy can be
done by using Confocal Microscopy instead of Fluorescent Microscopy in order to view in more
detail cellular morphology and microcapillary formation. Cell nuclei was stained with Hoechst
33342 dye at a working dilution of 1ug/mL in complete media and incubated for 1h. After the
incubation period of time, the Ti-6Al-4V scaffold was flipped upside down to better observe the
cells that grow on the uppermost section of the scaffold. Microscopy is performed in a Zeiss
Axiovert 200 fluorescent microscope.

2.9: Induction of angiogenesis in foams containing hypoxia mimetic ECM

It has been previously reported that MC3T3-E1 pre-osteoblast cells undergo
differentiation and proliferation when grown in porous foams in glutamine containing media [20
55 Nune]. It has been extensively reported that endothelial cells are able to form capillarities in
gels when exposed to DFM [28]. In this experiment, a live angiogenesis monitoring experiment
is performed in order to analyze capillarity maturation and cell survival. This analysis is
achieved by staining HUVECs with PHK26 Red Fluorescent Dye (Sigma) and MC3T3-E1 cells
with PKH67 Green fluorescent dye (Sigma). Both dyes stain cell membranes in an unspecific
way, while maintaining cellular viability for an extended period of time. MC3T3-E1 cells will be
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grown in foams as previously described in the Immunofluorescence Microscopy section, but
under hypoxic conditions (3.2μM DFM). The Ti-6Al-4V foams will be pre-incubated with preosteoblasts for a total of 7 days, with a negative hypoxia control being cells without any DFM.
The cells grown on the foams and gel were monitored throughout the duration of this
experiment. The foams will be removed from the wells and will be placed in 12 a well plate and
Matrigel® (Corning Life Sciences) will be added until the foam is completely covered. In order
to observe microcapillarity formation upon exposure of HUVECs to DFM, the manufacturer
specifications will be followed. Briefly, Matrigel® was thawed according to specifications (4⁰C
overnight) and added to a 24 well cell culture plate and allowed to gelate also according to
specifications (30-60 minutes at 37⁰C). HUVECs (70-80% confluency) are tripsinized, resuspended (1.2X105cells in 300μL of complete media (10% FBS)) and treated with 10μM of
DFM. The cell suspension was incubated at 37⁰C, 5% CO2 for 16 to 18 hours on the Matrigel
coated plate for 16-18 hours minutes. The formation of microcapillarities is measured by
confocal microscopy.

2.10: Total Protein Content

Cells will be grown for 6h, 24h and 48h in the presence of DFM at the previously
specified 1:5 dilutions. After the desired time periods they will be washed with cold 1X PBS and
lysed with Radioimmunoprecipitation (RIPA) protein lysis buffer (0.2% Triton X-100 + protease
inhibitor cocktail) for 30 min in an ice bath. The total protein content in the cells will be
estimated using the Bradford spectrophotometric protein assay. Briefly, 10uL of the cell lysate
will be mixed with 100uL of Bradford Reagent (Sigma) and re-suspended to homogenize the
solution on a 96 well plate. The absorbance will be measured at 595nm. A standard plot of
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absorbance as a function of bovine serum albumin (BSA) concentration will be obtained to
determine the concentration value of the experimental and control samples.

2.11: Western Blot Analysis

To further quantify the expression of specific proteins, a western blot analysis was
performed for Hif-1α and VEGF165. The western blot analysis was made using the cell lysate
previously described Total Protein Quantification protocol. A Sodium Dodecyl SulfatePolyacrylamide Gel Electrophoresis (SDS-PAGE) was made (7.5% acrylamide for Hif-1α
(93kDa) and 12% acrylamide for VEGF165 (38kDa)). The separated proteins were then
transferred to a PVDF membrane. The Hif-1α antibody at a 1:1,000 dilution in 1% BSA in 1X
TBST buffer was incubated for one hour at room temperature, followed by three 10 min washes
with TBST. A secondary anti-rabbit IgG HRP conjugated antibody was incubated for 30 minutes
at room temperature, followed also by subsequent washes with TBST. The immuno-blot was
then revealed by the ECL method in film.

2.12: Cell Morphology and Adhesion

Scanning Electron Microscopy was used to study the morphology, pore interconnectivity,
and in-growth of pre-osteoblasts upon exposure to DFM. Cells were grown for 7 & 14 days. The
negative control for this experiment is cells grown on foam samples without any hypoxic
inducing molecules. The cell-seeded samples were fixed with 2.5% glutaraldehyde in 0.1M
cacodylate buffer pH 7.4 for 20 min, rinsed with PBS, dehydrated with a graded series of ethanol
(25–100%) and critical point dried. Prior to examination of samples via SEM (Hitachi S-4800),
the samples were sputter-coated with 10 nm of palladium to ensure sample conductivity and
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improve image resolution. The calcium-content in the ECM will be estimated after the DFM
exposure via Energy Dispersive X-Ray Analysis (EDAX) in the SEM.

2.13: Osteoblast Differentiation by Alkaline Phosphatase Activity (ALP)

Because osteoblasts express Alkaline Phosphatase (ALP) significantly, its activity can be
used as a measure for cellular differentiation of pre-osteoblasts. The cell lysate obtained after
treating with RIPA lysis buffer was used to determine the alkaline phosphatase activity, using
ALP assay kit (Quantichrom). It has been previously reported that cell differentiation into
calcium mineralizing MC3T3-El cells is inhibited under lack of L-glutamine in the growth
media. A control for cellular differentiation will be a lysate of cells grown in L-glutamine rich
media (50mM). The absorbance at 405 nm will be measured via a spectrophotometer in a 96well microplate reader. The ALP activity (expressed as micromoles of converted pnitrophenol/min) was normalized by total intracellular protein synthesis (determined as described
in the total intracellular protein content protocol and expressed as micromoles of p-nitrophenol
per minute per milligram protein). ALP activity of osteoblasts cultured without any DFM and
Tissue Culture Plate (TCP) served as controls.

2.14: Alizarin Red S (ARS) Mineralization Assay

Because it is expected that pre-osteoblasts differentiate into osteoblasts under a hypoxic
condition, cells should mineralize calcium in the ECM. The study of mineralization of ECM can
be viewed as a measure or potential for bone formation. In this regard, Alizarin Red Assay
(ARS) (Sigma-Aldrich) was used qualitatively and quantitatively to indicate the presence of
calcium in the matrix. Cells were grown on foams at the selected optimum DFM concentration
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for 48 hours. The negative control for this experiment was cells grown in 3D printed foams in
complete media with no added glutamate. After incubation, the samples were washed carefully
with PBS without disturbing the cell layer and fixed with 4% paraformaldehyde for 30 minutes.
The 3D foam structures were then stained with alizarin red (pH~4.1) in dark and at room
temperature for 30 minutes. Samples were qualitatively studied via light microscope after rinsing
with PBS. The calcium nodules should appear red. To conduct quantitative analysis, 10% cetyl
pyridinium chloride will be added to remove the alizarin red stain. The absorbance of the
solution will be measured at 570 nm OD with a spectrophotometric microplate reader.

2.14: Statistical analysis of data

The data was normalized with respect to control experiments and expressed as the mean
of at least three replicates standard deviation (SD). Three sets of experiments were carried out for
each experimental run. Statistical analysis was performed using a one way analysis of variance
with 95% confidence interval.
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Summary of experiments performed and their significant contribution to the goal of achieving a
living implant.
Experiment
Seeding Efficiency
MTS Viability

Cell Proliferation Analysis
Immunofluorescent Analysis

Induction of Angiogenesis in Foams
Total Protein Content

Western Blot Analysis

Cell Morphology & Adhesion

Osteoblast Differentiation by ALP activity

Alizarin Red S Mineralization Assay

Purpose
Serves to determine the amount of cells that can be
grown on foams relative to its surface area.
Determines the viability of cells exposed to DFM
by measuring cellular metabolism. Toxicity of
DFM is compared to CoCl2; another hypoxia
inducer but produces adverse effects.
Measures the proliferation of cells exposed to DFM
by counting the number of viable cells.
Allows visual analysis of the cellular levels of
specific proteins such as Hif-1α and VEGF.
Provides with visual confirmation of cellular
density in foams.
This assay measures the formation of endothelial
microcapillarities
Quantifies the levels of total protein synthesized by
the cells and allows determining the rate at which
cells are differentiating in combination with the
ALP assay.
Allows visualizing and quantifying the amount of
specific proteins synthesized by cells. Serves to
confirm that the proposed cellular pathways are
being activated.
Provides with visual confirmation of cells growing
in foams through SEM analysis. Serves to calculate
levels of hydroxyapatite synthesized by cells and
observe its morphological features.
Determines the degree and rate of differentiation
that the cells are undergoing when exposed to DFM
and grown on foams.
Allows the visual and quantitative determination of
hydroxyapatite synthesized by cells exposed to
DFM and cells exposed to DFM grown on foams.

An immediate issue that needs to be addressed is to determine the correct concentration
of DFM needed to promote osteogenesis, bone formation and osteoblast differentiation coupled
with angiogenesis and endothelial cell quiescence. A concentration of DFM needs to be chosen
to promote these effects in both cell lines.
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Chapter 3: Results

3.1: Material fabrication, preparation and characterization

Ti-6Al-4V foams were successfully synthesized and characterized (figure 8). The
structure in question has a density of 1.77g/cm3 with 60% porosity and a modulus of 18GPa.The
average pore size was 350μm in diameter, estimated by SEM analysis (figure 9). Larger pores
(outer portion of the foam) averaged 500μm in diameter. The smaller pores (inner portion of the
foam) averaged 200μm in diameter.

Figure 8: EBM fabricated Ti-6Al-4V foam.
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Figure 9: SEM analysis of EBM fabricated Ti-6Al-4V foams. Samples were sliced to 0.5cm
thivkness for convenience and cleaned by ultrasonication in soap water (Alconox), ethanol,
acetone and distilled water prior to characterization.
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3.2: Seeding Efficiency

The efficiency of cell seeding in porous surfaces is directly related to the porosity of the
material. A higher degree of porosity leads to a more limited surface area in which cells may
grow and proliferate. Unlike mesh structures, foams are randomized and do not follow a
structural pattern. Therefore, the seeding efficiency of a foam surface is related to the thickness
of the sample. A thicker sample will yield a higher seeding efficiency value. A 0.5cm thick 60%
porous Ti-6Al-4V foam disk yields ~58% seeding efficiency value.

3.3: MTS Viability Assay

The evaluation of the viability of cells grown under hypoxia mimetic conditions must be
analyzed in order to determine the appropriate amount of stress that the cells are undergoing,
without promoting a cytotoxic effect. The degree of cellular metabolism needs to be assessed,
whether cells are grown on a plastic tissue culture plate, a porous metal surface, or a 3D ECM
matrix. This experiment serves the purpose of examining the optimal environmental conditions
in which cells are stimulated to activate survival signals. Figure X shows a comprehensive MTS
viability analysis by varying amount of exposure time and concentration of hypoxia mimetic
compounds. The compounds tested include a known toxic hypoxia mimetic (CoCl2) and the
proposed PHD-2 inhibitor at 1:5 dilutions ranging from 2mM to 640nM of each compound.
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MTS Viability Assay MC3T3-E1 DFM & CoCl2
dilution
3

2.5

DFM 24h

Abs 490nm

2

CoCl2 24h
DFM 48h
CoCl2 48h

1.5

72h DFM
72h CoCl2
DFM 5 days

1

CoCl2 5 days
DFM 14 days
CoCl2 14 days

0.5

0
C-

2mM

400uM

80uM

16uM

3.2uM

640nM

Concentration of DFM & CoCl2

Figure 10: Comprehensive MTS viability Assay of MC3T3-E1 pre-osteoblast cells exposed to
both CoCl2 and DFM.
As expected, high doses of both compounds decreases cell viability drastically. In most
cases, particularly at high concentrations CoCl2 completely eradicated all cells present in the
wells (figure 10). To the best of my knowledge the Lethal Dose at 50% (LD50) of CoCl 2 is not
known for pre-osteoblast or osteoblast cell populations. Notably, MTS metabolism greatly
increases for cells exposed to a hypoxia mimetic condition in periods of time equal or longer
than 72 hours for both DFM and CoCl2. This is in accordance to previous reports [28] which
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show that near 10μM concentrations of DFM can stimulate a survival response. Increased
viability at 72 hours of exposure can be attributed to the pre-osteoblast’s population doubling
time. It is important to mention that, though the goal of this research is to create a hypoxia
mimetic environment in the implant, the true levels of oxygen in the environment are not being
depleted. Depletion of oxygen de-regulates mitochondrial production of cellular energy. The
increased expression of Hif-1α and VEFG does not necessarily result in the de-regulation of
mitochondrial energy production processes. Previous reports demonstrate that Glutathione S
Transferase (GST) levels do not decrease with increased Hif-1α expression and the uptake of
glutamine and glucose significantly increases [39]. Excess glucose is required so that cells may
endure the hypoxic reprograming.

3.4: D(+) Glucose augments viability faster in HUVECs but not in MC3T3-E1

It has been previously suggested that the storage of glycogen increases in transplanted
cells in bone tissue [39]. The authors demonstrated that metabolic demand of glucose increases
in cells with an activated Hif-1α program. To understand the effects that D(+) glucose may have
on individual cell type populations, both HUVECs and MC3T3-E1 cells were exposed to
treatments of 3.2μM DFM, 5mM glucose, and a combination of the both for 24 hours. The
viability of cells was measured by MTS (figure 11).
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1.6
1.4

OD 490nm

1.2

MC3T3-E1 & HUVEC response to combinatorial
dose of D(+) glucose & DFM

1
0.8
MC3T3-E1

0.6

HUVEC

0.4
0.2
0
C-

3.2uM DFM

5mM glu

5mM glu + 3.2uM
DFM

Exposures

Figure 11: Viability test measuring response of HUVECs and MC3T3-E1 cells to DFM, D(+)
glucose and DFM + D(+) glucose.
It can be observed that there is no significant decrease in viability in both cell lines after
exposures. However, HUVECs seem to have a more positive response to the additional glucose
than the MC3T3-E1 cells. This may be explained due to HUVECs being more sensitive to
oxygen sensing reprograming than MC3T3-E1 cells, increasing metabolic demands more
significantly. This approach suggests that D(+) glucose may be used as a potential additive in the
gel matrix to help cells enhance a wound healing response and to better tolerate stress.

3.4: Proliferation Analysis

A cell count analysis is required in order to determine cellular proliferation. Cellular
metabolism of MTS is not necessarily a direct measure of an increase in proliferation. Therefore,
cell count experiments were performed by trypan blue exclusion dye method for MC3T3-E1
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cells. , As expected, a 24 hour exposure to both DFM and CoCl2 dilutions reveals a toxic
response to high concentrations of 2mM. Despite seeing no cellular growth in any of the 2mM
CoCl2 wells, there seems to be no immediate apparent loss of cellular proliferation in the
remaining wells. The wells containing cells exposed to DFM however, display constant cell
population numbers, with a slight decrease in numbers when compared to control cells that were
not exposed to any drug at 24 hours. The MTS analysis for cells exposed to both DFM and
CoCl2 for 24 hours shows almost no variation in cellular metabolism for the different amount of
drug concentrations. However, given that the cells exposed to CoCl2 are in fewer numbers and
the MTS metabolism remains constant, it could be interpreted that these cells are undergoing
stress and may be expressing cellular survival signaling.
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Figure 12: Trypan blue exclusion dye cellular proliferation analysis for MC3T3-E1 cells exposed
to DFM and CoCl2 for 24 hours.
Given that there is no immediate change in cellular population numbers, but metabolism
of MTS readily increases, it can be assumed that cells exposed to both DFM and CoCl2 are
expressing survival signaling pathways. This will be later analyzed in the western blot analysis
of p-Akt, Interestingly, more extended time exposures for DFM at high concentrations reveals an
obvious decrease in cellular proliferation. This was also expected, seeing as iron homeostasis is
no longer occurring due to DFM saturation. Despite this noticeable decrease, proliferation does
not reach untraceable levels, compared to CoCl2 exposed cell populations. An observable
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increase in proliferation can be especially seen in cells exposed to the lowest concentrations of
both DFM and CoCl2 (3.2μM & 640nM). These results prove to be of significant importance
given that it has been previously reported that HUVECs undergo angiogenesis at approximately
10μM DFM [28]. The data obtained from suggests that both these cell types can be co-cultured,
exposed to low concentrations of DFM (10-1μM) and achieve a hypoxia mimetic response that
can trigger survival signaling pathways.

3.5: Fluorescent Microscopy

As previously shown in a research paper by Murr et, al, MC3T3-E1 cells grow and
proliferate in Ti-6Al-4V foams of varying porosity, and a Hoechst 33342 staining in this case
yielded similar results (figure 13).

Figure 13: Hoechst 33342 staining of MC3T3-E1 cells grown in 60% porous Ti-6Al-4V
foam for 7 days.
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Once the appropriate concentration of DFM was determined, MC3T3-E1 cells were
seeded and grown in the Ti-6Al-4V foam for 21 days exposed to 3.2μM DFM in a 12 well plate.
Figure 14 shows a Hoechst 33342 cell nuclei staining for this experiment. This staining shows
that pre-osteoblasts are proliferating in the foam under a hypoxia mimetic environment. A
second staining was performed with the Vybrant® CFDA SE Cell Tracer Kit to visually
determine the degree of cellular viability in the foam.

Figure 14: MC3T3-E1 cells grown on foams for 21 days with no DFM.
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Figure 15: On top: MC3T3-E1 cells grown for 21 days exposed to 3.2μM DFM and
stained with Hoechst 33342 nuclei staining dye. Bottom: MC3T3-E1 cells grown for 21 days
exposed to 3.2μM DFM and stained with Vybrant® CFDA SE Cell Tracer Kit.
When HUVECs experience hypoxic stress, VEGF is secreted, and in turn, this signals
neighboring cells to undergo a migration process to form microvasculature. In this experiment,
the levels of secreted VEGF were analyzed by fluorescent microscopy techniques by staining
VEGF with a fluorescently marked antibody.
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3.6: Induction of angiogenesis in foams containing hypoxia mimetic ECM

The capacity an implant has to enable the formation of vascular structures is of critical
importance, and therefore a requisite in order to consider the structure as a “living implant”. In
this experiment, angiogenesis is induced in endothelial cells through exposure to DFM while
grown in a 3D collagen based hydrogel. The hydrogel was polymerized in the presence of the
printed Ti-6Al-4V foam. Seeing as it has been previously shown that HUVECs exposed to DFM
undergo a reorganization process to form capillarity in Matrigel® [28, 52], the real purpose of
this experiment is to analyze whether this process could be interrupted by the presence of metal
foams. This experiment was designed to study the formation of capillarity by fluorescent
microscopy for an extended period of time while maintaining cell viability. To achieve this,
HUVEC membrane was stained with PKH26 (red fluorescence) whereas MC3T3-E1 cell
membrane was stained with PKH67 (green fluorescence) (figure 17).

Figure 16: HUVECs stained with PKH26 Red fluorescent dye.
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Figure 17: MC3T3-E1 cells stained with PKH67 green fluorescent dye.
Once successful staining was confirmed, Ti-6Al-4V foams were seeded with 2X105
fluorescently labeled MC3T3-E1 cells and incubated for 12 hours to allow cellular adherence.
After expiration of this time, Matrigel® was added to the foam containing the pre-incubated
MC3T3-E1 cells. After an 18 hour period, HUVECs that were exposed to 2mM DFM readily
formed capillarities (figure 18 bottom), suggesting the success of the approach. In the control
setting (no DFM), these capillarities were not apparent (figure 18 top). The integrity of the
capillarites could not be measured. However, the capillarities seem to maintain their structure for
an extended period of time. This can be measured because the cells used in this assay fluoresce
without having to fix cells or stain with toxic dyes.
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Figure 18: Top: HUVECs with no DFM treatment in Matrigel. Bottom: HUVECs with 2mM
DFM treatment after 18 hours (Day 1).
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The branching of these structures seems apparent, and it is consistent with previous
reports [28].

Figure 19: HUVECs with 2mM DFM treatment (Day 2). HUVECs in control wells do not form
vascular networks (data not shown).
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Figure 20: HUVECs with 2mM DFM treatment (Day 3). HUVECs in control wells do not form
vascular networks (data not shown).

After the confirmation of the formation of vascular networks in Matrigel, MC3T3-E1
cells staining and survival were analyzed (figure 18, 19, 20).
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Figure 21: MC3T3-E1 cells stained with PHK67 (Green) on foams and Matrigel. Above: No
DFM. Bellow: 3.2uM DFM exposed cells.

After successful confirmation of the presence of MC3T3-E1 cells on foams and gels
(figure 21), HUVECs were then added to the well containing foam + gel with pre incubated
MC3T3-E1 cells. HUVECs were added according to the Matrigel’s manufacturer specifications.
As previously mentioned, the experimental setting were HUVECs treated with 2mM DFM at the
moment of cellular resuspension.
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Figure 22: Vascular network formation on foams and Matrigel mix under DFM treatment.
HUVECs (Red) & MC3T3-E1 (Green).

Fluorescent microscopy becomes challenging when analyzing 3D cell cultures, while
solid foams also add complexity to the analysis. Figure 22 demonstrates that vascular structures
may form in foams with an ECM-like hydrogel matrix. This result is central to the demonstration
that vascularization is achievable in these materials, and supports the hypothesis that a foam does
not present a physical barrier that hinders this biological process. Further optimizations are
required however, to establish the occurrence of this process in greater detail and resolution.
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3.7: Total Protein Content

In order to assess the total levels of protein being synthesized by cells exposed to DFM, a
Total Protein Quantification analysis was performed in both HUVECs and MC3T3-E1 cells to
show that protein levels do not decrease with DFM exposure. Figures 23 & 24 show the levels of
total protein in cell lysates.

7.000

HUVEC DFM total protein quantification
6.000

Protein mg/mL

5.000
4.000
HUVEC 6h DFM
3.000

HUVEC 24h DFM
HUVEC 48h DFM

2.000
1.000
0.000
C-

2mM

400uM

80uM

16uM

3.2uM

640nM

DFM concetration

Figure 23: Total protein quantification of HUVECs exposed to DFM 1:5 dilutions for 6, 24 and
48 hours estimated by Bradford Assay.
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Figure 24: Total protein quantification of MC3T3-E1 cells exposed to DFM 1:5 dilutions for 24
and 48 hours estimated by Bradford Assay.
No obvious changes are observed in the levels of total protein synthesized by the
endothelial cells. However, this analysis will further provide information as to the rate of cellular
differentiation in pre-osteoblasts exposed to DFM.
3.8: Hif-1α & VEGF165 Western Blot Analysis of HUVECs exposed to DFM
It has been previously reported that Hif-1α is barely detectable in HUVECs under
normoxia. However, under the presence of low oxygen concentrations (pO2<5%), intracellular
levels of Hif-1α begin to increase [28]. This effect has been shown in HUVECs under DFM
treatment. Here we can observe a relation between the administered concentration of DFM and
the levels of intracellular Hif-1α. The cells barely express Hif-1α under normoxia, whereas high
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doses (2mM) of DFM notably increase Hif-1α expression (figure X). Regardless of the amount
of time of exposure to DFM, the production of Hif-1α maintains its stability. Cells exposed to
DFM for 48 hours are still producing definitive bands of total intracellular Hif-1α (figure 25).
These results demonstrate the ability of DFM to maintain the hypoxia mimetic response.

Figure 25: Western Blot analysis of Hif-1α of HUVECs treated with DFM dilutions for 48 hours.

3.9: Cell Morphology and Adhesion

The distribution of cellular growth on the implant was analyzed by SEM imaging. SEM
provides the advantage of analyzing the porous surface in which the pre-osteoblasts grow. It has
been previously shown that MC3T3-E1 cells undergo cell differentiation when grown in foams
of various densities under pre-osteoblast differentiation media (α-MEM 10% FBS + Glutamine)
[55]. Figure X shows MC3T3-E1 cells grown for 21 days in non-differentiation media on a 60%
porous Ti-6Al-4V foam.
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Figure 26: SEM imaging of MC3T3-E1 cells grown for 21 days in a 60% porous Ti-6Al-4V
foam in non-differentiation media.
An SEM analysis was made in the same foam (figure 26), but under a hypoxic mimetic
environment with DFM. As previously shown, MC3T3-E1 cells undergo a drastic morphological
change under the presence of DFM. The cells display an “elongation” which imparts on them a
fibroblastic morphology.

3.10: Alkaline Phosphatase Differentiation Assay

Because of the drastic morphological change on the pre-osteoblast cells, while
maintaining viability, it is suspected that the hypoxia mimetic stress indices cellular
differentiation.

3.11: Alizarin Red S Mineralization Assay

It has been previously reported that MC3T3-E1 cells undergo cellular differentiation into
osteoblasts in foams and other Ti-6Al-4V surfaces, and that they are able to mineralize calcium
when grown in these surfaces [55]. Under ARS staining, the calcium nodes synthesized by the
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cells are apparent, particularly for lower DFM concentrations. The cells underwent evident
morphological changes, as previously seen under DFM exposures (figure 28).
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ARS analysis of MC3T3-E1 cells exposed to DFM
at various concentrations
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Figure 27: Alizarin Red S staining assay performed on MC3T3-E1 cells exposed to various
concentrations of DFM.
The synthesis of hydroxyapatite can be interpreted as a sign of pre-osteoblast
differentiation given that the cell’s phenotype expresses forms of mineralized calcium nodes.
Despite seeing calcium nodes as early as 7 days, the production of hydroxyapatite is small in
quantity, which correlates with previous reports [55]. However, synthesis of this main
component of bone structure is mostly observed at lower concentrations of DFM. This data
compliments that of cellular viability and proliferation in which we see increased metabolism,
while maintaining cellular population at lower DFM concentrations, suggesting that said
concentrations of DFM are sufficient to stimulate a desired effect of bone formation. Not only
are the cells proliferating, but differentiating into a phenotype that promotes structural bone
49

component formation. At 14 days of exposure to DFM the calcium nodes begin to look more
obvious in all the wells when compared to a 7 day exposure. In all of the wells the levels of
mineralized calcium seem apparent but they are most notable in the lower DFM concentration
exposures. The highest expression of mineralized calcium can be observed at the 640nM DFM
exposed cells for 21 days (figure 27). Notably, in every instance, the expression of
hydroxyapatite is always in greater amount for the cells exposed to 640nM DFM when compared
to control cells. This leads to the conclusion that DFM in fact increases the production of
mineralized calcium.
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Figure 28: Alizarin Red S staining assay of MC3T3-E1 cells exposed to various DFM
concentrations for 7 days. Top Right: Control cells not exposed to DFM. Top left: Cells exposed
to 16μM DFM. Bottom Right: Cells exposed to 3.2μM DFM. Bottom left: Cells exposed to
640nM DFM.
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Figure 29: Alizarin Red S staining assay of MC3T3-E1 cells exposed to various DFM
concentrations for 14 days. Top Right: Control cells not exposed to DFM. Top left: Cells
exposed to 640nM DFM. Bottom Right: Cells exposed to 2mM DFM. Bottom left: Cells
exposed to 3.2uM DFM.
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Figure 30: Alizarin Red S staining assay of MC3T3-E1 cells exposed to various DFM
concentrations for 21 days. Top Right: Control cells not exposed to DFM. Top left: Cells
exposed to 80μM DFM. Bottom Right: Cells exposed to 3.2μM DFM. Bottom left: Cells
exposed to 640nM DFM.
It has been previously shown that MC3T3-E1 cells undergo cellular differentiation and
successfully synthesize hydroxyapatite when grown on 3D printed Ti-6Al-4V foams [55]. Here,
it is demonstrated that cellular production of hydroxyapatite can be enhanced by addition of
3.2μM DFM.
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ARS Analysis of MC3T3-E1 cells on foams
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Figure 31: ARS analysis performed on MC3T3-E1 cells grown in foams for 7, 14 and 21
days. Negative controls (blue) represent cells without DFM exposure. Experimental setting (red)
represents cell exposed to 3.2μM DFM.
Initially, there is a definitive amount of hydroxyapatite being synthesized by the
osteoblasts in both cases. Cells exposed to DFM express comparatively similar amounts of
hydroxyapatite to control cells. Regardless of the hypoxic mimetic stress, where cells may be
metabolically challenged to survive, the synthesis of hydroxyapatite does not seem to be
suppressed. This can also be observed at longer time exposures of 14 days, the synthesis levels of
hydroxyapatite seem to increase on par in both settings. After 21 days of exposure, the amount of
cellular hydroxyapatite dramatically increases on the foam with cells exposed to DFM (figure
31). The foam containing cells exposed to 3.2μM DFM displays a regular coating of
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hydroxyapatite (orange), and in considerably larger amounts than the control grown without
DFM (figure 32-33).

Figure 32: Left: ARS staining on foams after 21 day MC3T3-E1 incubation with no
DFM. Right: ARS staining on foams after 21 day NC3T3-E1 incubation with 3.2μM DFM.

Figure 33: ARS stained foam. MC3T3-E1 cells were grown for 21 days exposed to
3.2μM DFM.
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Summary of results of experiments performed:
Experiment
Seeding Efficiency
MTS Viability

Cell Proliferation Analysis

Fluorescent Microscopy Analysis

Induction of Angiogenesis in Foams

Total Protein Content

Western Blot Analysis
Cell Morphology & Adhesion
Osteoblast Differentiation by ALP activity
Alizarin Red S Mineralization Assay

Results
A seeding efficiency of 58% was achieved on a
0.5cm thick 60% porous foam disk
Cellular viability does not decrease in MC3T3-E1
cells exposed to DFM. Viability increases with
lower DFM concentrations, as well as CoCl2.
Proliferation of MC3T3-E1 cells is affected at high
DFM concentrations, but is increased in lower
concentrations.
MC3T3-E1 cells grow and proliferate on the foam
alloy when exposed to low DFM concentrations for
a long period of time.
HUVECs readily undergo migration to form
capillarities in gels and in foams with gel mixtures
when exposed to DFM.
Total protein contents were analyzed and further
used in the Western Blot analysis and the ALP
analysis.
Hif-1α levels increased with increasing DFM
concentration in HUVECs.
Visual confirmation of cells growing in foams
through SEM analysis has been confirmed.
DFM enhances the cellular production of
hydroxyapatite both in cells grown in plates and in
foams.
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Chapter 4: Discussion

This research was conducted to examine the possibility of successfully achieving
vascular structure formation in additive manufactured Ti-6Al-4V foams in order to design a fully
living implant. The obtained results from the conducted experiments show that this proposed
approach can be utilized as a potential prototype for bone replacement implants. Foams provide
an ideal substrate to substitute bone due to their random distribution and interconnection, which
is largely similar to that of real bone. Ti-6Al-4V has been a popular alloy used in the biomedical
industry and research and has been extensively characterized[56-59]. The limitation of free iron
availability through exposure of DFM seems to be a driving factor to enhance the synthesis of
hydroxyapatite by cells. It has been previously demonstrated that pre-osteoblasts proliferate,
differentiate and are able to synthesize hydroxyapatite when grown on foam and mesh structures
of this alloy. However, this is the first time that the formation of a vascular network formation
has been achieved in the presence of this foam alloy. The process of vascular structure initiation
has a key step that involves proteolytic degradation of the ECM so that endothelial cells can
migrate to form the microcapillarities [28]. DFM has proven to be a suitable candidate molecule
to promote vascularization of endothelial cells. Immediate biomedical applications of this iron
chelating agent are viable, seeing as it is already been FDA approved for the treatment of iron
poisoning. This research has greatly focused on the process of forming a vascular network.
However crucial this step may be, the concept of a living implant pertains to various other
cellular molecular mechanisms, mainly involved in wound healing and the regeneration of tissue.
Tissue that has undergone extensive damage needs to endure harsh environments that stimulate
apoptosis rather than cell survival. A tissue-solid metal interface is not sufficient to promote a
wound healing process, the ingrowth of bone, and eventually the formation of a vascular
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network. Implanted solid metal bars present a physical limitation to the availability of nutrients
and, most notably, oxygen. The wounded tissue then suffers from hypoxia, triggering an
irreversible response that eventually leads to cellular death. In a heavily wounded tissue
metabolic demands differ vastly from that of normal tissue. To create a fully living implant that
mimics real tissue, this issue needs to be addressed and thoroughly understood. Therefore, the
addition of molecules that can compensate for the metabolic high demands is required. It is to
this end that D(+) glucose was added to cells undergoing a hypoxia mimetic response. The
addition of glutamine to enhance cell survival is also suggested by Stegen et.al. 2016. in order to
reduce the production of ROS through Glutathione, which is a powerful biological reducing
agent.

The materials chosen and tested in this research prove to be a combination that is suitable
to develop a fully living bone replacement implant. Ti-6Al-4V foams provide structural support,
while an ECM-like hydrogel simulates an aqueous microenvironment that drives wound healing,
bone ingrowth and vascularization. Despite the attractive properties of Matrigel, this product is
not intended for anything other than research purposes. However, its main constituents may be
further utilized with the focus of creating a hydrogel capable of driving the before mentioned
processes. Collagen and gelatin hydrogels can be tailored to maintain their solid stability under
physiological conditions [5, 60]. Despite the success of achieving vascularization in the presence
of Ti-6Al-4V foams, in vivo implantation of this mix of materials is required for a more
comprehensive analysis of the ingrowth of bone and the ability of vascular networks to form.
The effects of mechanical loading on the hydrogel matrix in Ti-6Al-4V foams are in need of
evaluation [61, 62]. There is need of further analysis of the metabolic demands of stressed
tissues, mainly in areas where the availability of oxygen is limited. Another approach to optimize
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the delivery of DFM in hydrogels could be the microencapsulation of DFM and adding the
microcapsules as a gradient in the gels [63]. This may enable the specific driving of tissue
ingrowth into the implant. This approach could also be applied to siRNAs that silence PHD-2
activity [39]. Utilizing siRNAs could be a more suitable approach due to its specificity. Iron
chelation is not specific as to the processes that may be altered. Iron (III) is a necessary
supplement as it is used as a cofactor to various enzymes, and it is also necessary for electron
transport in aerobic metabolism. However, with respect to bone tissue repair, the limitation of
iron (III) availability decreases bone resorption [53, 64]. This suggests that this limitation should
enhance the ingrowth of bone but it may also affect other unrelated cellular processes.

This research proves that additive manufactured Ti-6Al-4V foams do not present a
physical barrier, nor do they inhibit the formation of an endothelium network under
physiological conditions. The foam itself is not able to drive this process, but the combination of
materials and effecting molecules is sufficient to cause its desired effect. Soluble DFM in a
hydrogel matrix demonstrated to help drive angiogenesis and enhance the synthesis of
hydroxyapatite.

Conclusions

This work demonstrates that a mixture of additive manufactured Ti-6Al-4V foam in
combination with a collagen based hydrogel matrix containing DFM; a hypoxia mimetic
compound, can form vasculature under physiological conditions, while maintaining osteoblast
cell differentiation and proliferation. This approach induces a hypoxia mimetic stress that will
trigger cellular survival signals that ultimately enhances wound healing processes in bone.
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The conclusions from this research are summarized as follows:

1. Additive Manufactured Ti-6Al-4V foams in combination with Matrigel infused with
DFM allows vascular network formation.
2. DFM improves pre-osteoblast differentiation and synthesis of hydroxyapatite both in
tissue culture plates and in foams.
3. Vascular networks maintain their stability in gels for extended periods of time in
Matrigel.
4. Foams prove to be a suitable material to allow the ingrowth of bone.
5. Further research is required to understand and meet the metabolic demands of
damaged/stressed tissue to promote the ingrowth of bone.

Together, this data ultimately serves to reach the goal of creating a living implant.
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